The clinical impact of plasma estrogen receptor-1 mutation in patients with metastatic breast cancer: A meta-analysis

CONCLUSION: According to the findings of this meta-analysis, the assessment for plasma ESR1 mutations may provide prognostic and clinical guidance regarding subsequent endocrine therapy decisions for ER-positive, metastatic BC patients who had received prior therapy with AIs.PMID:38353504 | DOI:10.17219/acem/175816

Source: Clinical Breast Cancer - February 14, 2024 Category: Cancer & Oncology Authors: Xiaoli Zhang Ye Tian Dan Mo Wenli Chen Yi Ding Yanjiang Yang Xinning Li Source Type: research